Real World Evidence
Real world evidence. Real confidence. Real impact.
IQVIA helps our customers generate real world evidence (RWE) to unlock the value of their investment at every stage of the product life cycle.
IQVIA helps our customers generate real world evidence (RWE) to unlock the value of their investment at every stage of the product life cycle.
The healthcare environment today is more specialized, more competitive, and more cost sensitive than ever before. We’re in a “prove-it” era. RWE provides scientific proof points from actual clinical practice to ensure that clinical and commercial decisions are made with a true patient focus.
RWE has been used for decades to characterize a product’s safety and effectiveness post approval, to demonstrate a product’s value, cost-effectiveness, and budget impact as well as to optimize commercial spending. The pandemic has underscored the urgent need to understand how diseases progress and to quickly assess potential therapies. There’s now a place for RWE in biomarker and drug discovery, clinical development, and supporting regulatory submissions.
IQVIA is leading the way in delivering on the promise of RWE. Our data, analytics, and expert support allows life sciences companies to distinguish themselves clinically and commercially. We offer:
The market dynamics and patient behavior that underlie performance